Sanchez-Lopez, Elsa
Ghia, Emanuela M.
Antonucci, Laura
Sharma, Natasha
Rassenti, Laura Z.
Xu, Jinyi
Sun, Beicheng
Kipps, Thomas J.
Karin, Michael
Funding for this research was provided by:
Leukemia and Lymphoma Society (7005-14, 7005-14)
Leukemia and Lymphoma Society
Article History
Received: 18 July 2019
Revised: 9 January 2020
Accepted: 10 January 2020
First Online: 28 January 2020
Compliance with ethical standards
:
: Cirmtuzumab was developed in the Kipps laboratory and licensed by the University of California, San Diego to Oncternal, which has provided stock/options to the university and to TJK.